BCR-ABL CML AML ALL Genetic Test
Comprehensive Leukemia Genetic Screening
The BCR-ABL CML AML ALL Genetic Test represents a breakthrough in leukemia diagnosis and monitoring. This sophisticated genetic analysis detects the presence of the Philadelphia chromosome, a specific chromosomal abnormality that results from a translocation between chromosomes 9 and 22. This translocation creates the BCR-ABL fusion gene, which produces an abnormal protein that drives uncontrolled cell growth in several types of leukemia.
What This Revolutionary Test Detects
Our advanced genetic screening specifically identifies:
- The BCR-ABL fusion gene resulting from t(9;22) translocation
- Presence of Philadelphia chromosome in blood or bone marrow cells
- Genetic markers for Chronic Myeloid Leukemia (CML)
- Specific subtypes of Acute Lymphoblastic Leukemia (ALL)
- Certain cases of Acute Myeloid Leukemia (AML)
- Quantitative measurement of BCR-ABL transcript levels
Who Should Consider This Critical Screening?
Individuals Experiencing These Symptoms
- Unexplained fatigue, weakness, or persistent tiredness
- Frequent infections or slow healing
- Unexplained weight loss or night sweats
- Easy bruising or excessive bleeding
- Bone pain or tenderness
- Enlarged spleen causing abdominal discomfort
- Pale skin or shortness of breath
- Fever without apparent cause
High-Risk Populations
- Patients with abnormal blood counts showing elevated white blood cells
- Individuals with family history of leukemia or blood disorders
- Patients previously exposed to high radiation or chemotherapy
- Those with previous cancer diagnoses requiring monitoring
- Individuals with unexplained splenomegaly
Transformative Benefits of Early Detection
Life-Saving Advantages
- Early Diagnosis: Detect leukemia in its earliest stages when treatment is most effective
- Precision Treatment: Guide targeted therapy decisions with tyrosine kinase inhibitors
- Treatment Monitoring: Track response to therapy and detect resistance early
- Prognostic Information: Understand disease progression and survival expectations
- Minimal Residual Disease Detection: Identify low levels of leukemia cells after treatment
- Personalized Care: Enable customized treatment plans based on genetic markers
Understanding Your Test Results
Interpreting BCR-ABL Findings
Your test results will provide crucial information about your genetic profile:
Positive Result Interpretation
- BCR-ABL Detected: Indicates presence of Philadelphia chromosome
- Quantitative Levels: Higher levels may indicate more active disease
- Treatment Guidance: Positive results typically respond well to targeted therapies
- Monitoring Baseline: Establishes starting point for treatment response tracking
Negative Result Interpretation
- No BCR-ABL Detected: Suggests absence of Philadelphia chromosome
- Alternative Diagnosis: May indicate different leukemia subtypes
- Treatment Success: In treated patients, indicates successful response
- Regular Monitoring: May require continued surveillance based on symptoms
Next Steps After Testing
- Consult with your oncologist for comprehensive result interpretation
- Discuss appropriate treatment options based on findings
- Establish regular monitoring schedule if positive
- Consider additional testing if negative but symptoms persist
- Follow up with recommended specialists for comprehensive care
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | BCR-ABL CML AML ALL Genetic Test |
| Regular Price | $176 USD |
| Discount Price | $132 USD |
| Turnaround Time | 3-4 Days |
| Sample Type | Bone Marrow / Peripheral Blood |
| Test Components | Sodium Heparin Vacutainer (2ml) |
| Methodology | FISH (Fluorescence In Situ Hybridization) |
Convenient Testing Across the United States
We have branches in all major cities across the USA, making it easy for you to access this critical genetic testing. Our state-of-the-art facilities in New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose ensure you receive the highest quality care and accurate results.
Pre-Test Instructions
The BCR-ABL (CML, AML, ALL) test requires a Doctor’s prescription for most cases. Please note that prescription requirements do not apply for surgery and pregnancy cases or individuals planning to travel abroad. Our team will guide you through the simple preparation process.
Take Control of Your Health Today
Don’t wait for symptoms to progress. Early detection of leukemia through BCR-ABL testing can significantly improve treatment outcomes and quality of life. Our expert team is ready to provide you with comprehensive genetic screening and support throughout your healthcare journey.
Book Your Test Now
Call or WhatsApp us today at +1(267) 388-9828 to schedule your BCR-ABL genetic test. Our compassionate healthcare professionals will answer all your questions and help you take the first step toward understanding your genetic health. With rapid 3-4 day results and comprehensive support, we’re here to guide you through every step of the process.
Your health is our priority. Contact us now to book your appointment and take advantage of our special pricing at only $132 USD.
